News&lnfo
RecBio is a high-tech enterprise jointly founded by the former vaccine R & D expert team from the Chinese Center for Disease Control and Prevention (China CDC) and the senior vaccine industrialization team.
The company has established a leading domestic R & D and innovation platform for new adjuvants, genetic engineering, and immune evaluation.

20200518

  • Categories:企业里程碑
  • Author:
  • Origin:
  • Time of issue:2020-05-18
  • Views:0

(Summary description)On May 18, 2020, the construction of RecBio HPV vaccine industrialization project production base was started.

20200518

(Summary description)On May 18, 2020, the construction of RecBio HPV vaccine industrialization project production base was started.

  • Categories:企业里程碑
  • Author:
  • Origin:
  • Time of issue:2020-05-18
  • Views:0
Information

On May 18, 2020, the construction of RecBio HPV vaccine industrialization project production base was started.

Scan the QR code to read on your phone

Previous: 20190328
Previous: 20190328
  • TOP   

Contact Us

底部联系方式

Time of issue:2022-03-29 08:59:20

Jiangsu Recbio Technology Co., Ltd.

Media Inquiry: media@recbio.cn

Investor Inquiry: ir@recbio.cn

 

Address: Vaccine Engineering Center, China Medical City, Taizhou

Copyright © 2020 Jiangsu Rec-Biotechnology Co., Ltd.  All rights reserved.      苏ICP备19043567号-1